FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4383482251> ?p ?o ?g. }

• W4383482251 abstract "Journal of Medical VirologyVolume 95, Issue 7 e28907 LETTER TO THE EDITOR Comment on Huang PS et al. Clinical efficacy and safety of molnupiravir for nonhospitalized and hospitalized patients with COVID-19: A systematic review and meta-analysis of randomized control trials. Med Virol. 2023; 95: e28621 Chienhsiu Huang, Corresponding Author Chienhsiu Huang [email protected] [email protected] orcid.org/0000-0003-1239-9584 Department of Internal Medicine, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi County, Taiwan Correspondence Chienhsiu Huang, Department of Internal Medicine, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, No. 2, Min-Sheng Rd, Dalin Town, Chiayi County, Taiwan. Email: [email protected] and [email protected]Search for more papers by this author Chienhsiu Huang, Corresponding Author Chienhsiu Huang [email protected] [email protected] orcid.org/0000-0003-1239-9584 Department of Internal Medicine, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi County, Taiwan Correspondence Chienhsiu Huang, Department of Internal Medicine, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, No. 2, Min-Sheng Rd, Dalin Town, Chiayi County, Taiwan. Email: [email protected] and [email protected]Search for more papers by this author First published: 07 July 2023 https://doi.org/10.1002/jmv.28907Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1Huang PY, Liu TH, Wu JY, et al. Clinical efficacy and safety of molnupiravir for nonhospitalized and hospitalized patients with COVID-19: asystematic review and meta-analysis of randomized control trials. J Med Virol. 2023; 95:e28621. 2Caraco Y, Crofoot GE, Moncada PA. Phase /3 trial of molnupiravir for treatment of Covid-19 in nonhospitalized adults. NEJM Evid. 2022; 1(2):EVIDoa2100043. 3Bernal AJ, GomesdaSilva MM, Musungaie DB, et al. Molnupiravir for oral treatment of Covid-19 in nonhospitalized patients. N Engl J Med. 2022; 386(6): 509-520. 4Tippabhotla SK, Lahiri S, D RR, Kandi C, V NP. Efficacy and safety of molnupiravir for the treatment of non-hospitalized adults with mild Covid-19: a randomized, open-label, parallel group phase trial 3 trial. Lancet. 2022. https://ssrn.com/abstract=4042673 5Arribas JR, Bhagani S, Lobo SM. Randomized trial of molnupiravir or placebo in patients hospitalized with Covid-19. NEJM Evid. 2022; 1(2):EVIDoa2100044. 6Khoo SH, FitzGerald R, Saunders G, et al. Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARSCoV- 2 infection in the UK (AGILE CST-2): a randomised, placebo controlled, double-blind, phase 2 trial. Lancet Infect Dis. 2022; 23: P183-P195. 7Butler CC, Hobbs FDR, Gbinigie OA, et al. Molnupiravir plus usual care versus usual care alone as early treatment for adults with Covid-19 at increased risk of adverse outcomes (panoramic): an open-label, platform-adaptive randomized controlled trial. Lancet. 2022; 401: P281-P293. 8Ritchie H, Ortiz–Ospina E, Beltekian D, et al. Our world in data: Coronavirus (COVID-19) Vaccinations. Accessed March 23, 2023. https://ourworldindata.org/covid-vaccinations Volume95, Issue7July 2023e28907 ReferencesRelatedInformation" @default.
• W4383482251 created "2023-07-08" @default.
• W4383482251 creator A5073857411 @default.
• W4383482251 date "2023-07-01" @default.
• W4383482251 modified "2023-10-18" @default.
• W4383482251 title "Comment on Huang PS et al. Clinical efficacy and safety of molnupiravir for nonhospitalized and hospitalized patients with COVID‐19: A systematic review and meta‐analysis of randomized control trials. <i>Med Virol</i>. 2023; 95: e28621" @default.
• W4383482251 cites W4200051875 @default.
• W4383482251 cites W4200200825 @default.
• W4383482251 cites W4200427862 @default.
• W4383482251 cites W4306828790 @default.
• W4383482251 cites W4312134853 @default.
• W4383482251 cites W4322496518 @default.
• W4383482251 doi "https://doi.org/10.1002/jmv.28907" @default.
• W4383482251 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37417333" @default.
• W4383482251 hasPublicationYear "2023" @default.
• W4383482251 type Work @default.
• W4383482251 citedByCount "0" @default.
• W4383482251 crossrefType "journal-article" @default.
• W4383482251 hasAuthorship W4383482251A5073857411 @default.
• W4383482251 hasConcept C126322002 @default.
• W4383482251 hasConcept C161191863 @default.
• W4383482251 hasConcept C168563851 @default.
• W4383482251 hasConcept C17744445 @default.
• W4383482251 hasConcept C199539241 @default.
• W4383482251 hasConcept C2779134260 @default.
• W4383482251 hasConcept C2779473830 @default.
• W4383482251 hasConcept C3008058167 @default.
• W4383482251 hasConcept C41008148 @default.
• W4383482251 hasConcept C512399662 @default.
• W4383482251 hasConcept C524204448 @default.
• W4383482251 hasConcept C556039675 @default.
• W4383482251 hasConcept C71924100 @default.
• W4383482251 hasConcept C95190672 @default.
• W4383482251 hasConceptScore W4383482251C126322002 @default.
• W4383482251 hasConceptScore W4383482251C161191863 @default.
• W4383482251 hasConceptScore W4383482251C168563851 @default.
• W4383482251 hasConceptScore W4383482251C17744445 @default.
• W4383482251 hasConceptScore W4383482251C199539241 @default.
• W4383482251 hasConceptScore W4383482251C2779134260 @default.
• W4383482251 hasConceptScore W4383482251C2779473830 @default.
• W4383482251 hasConceptScore W4383482251C3008058167 @default.
• W4383482251 hasConceptScore W4383482251C41008148 @default.
• W4383482251 hasConceptScore W4383482251C512399662 @default.
• W4383482251 hasConceptScore W4383482251C524204448 @default.
• W4383482251 hasConceptScore W4383482251C556039675 @default.
• W4383482251 hasConceptScore W4383482251C71924100 @default.
• W4383482251 hasConceptScore W4383482251C95190672 @default.
• W4383482251 hasIssue "7" @default.
• W4383482251 hasLocation W43834822511 @default.
• W4383482251 hasLocation W43834822512 @default.
• W4383482251 hasOpenAccess W4383482251 @default.
• W4383482251 hasPrimaryLocation W43834822511 @default.
• W4383482251 hasRelatedWork W1967911880 @default.
• W4383482251 hasRelatedWork W2469512664 @default.
• W4383482251 hasRelatedWork W2914141471 @default.
• W4383482251 hasRelatedWork W3018215126 @default.
• W4383482251 hasRelatedWork W3036269150 @default.
• W4383482251 hasRelatedWork W3159250744 @default.
• W4383482251 hasRelatedWork W4256514411 @default.
• W4383482251 hasRelatedWork W4292236216 @default.
• W4383482251 hasRelatedWork W2083697902 @default.
• W4383482251 hasRelatedWork W2903040050 @default.
• W4383482251 hasVolume "95" @default.
• W4383482251 isParatext "false" @default.
• W4383482251 isRetracted "false" @default.
• W4383482251 workType "article" @default.